Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling

Purpose: As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus t...

Full description

Saved in:
Bibliographic Details
Published inGenetics in medicine Vol. 17; no. 6; pp. 467 - 475
Main Authors Butrick, Morgan, Kelly, Scott, Peshkin, Beth N., Luta, George, Nusbaum, Rachel, Hooker, Gillian W., Graves, Kristi, Feeley, Lisa, Isaacs, Claudine, Valdimarsdottir, Heiddis B., Jandorf, Lina, DeMarco, Tiffani, Wood, Marie, McKinnon, Wendy, Garber, Judy, McCormick, Shelley R., Schwartz, Marc D.
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.06.2015
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose: As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling. Methods: Methods include multivariable logistic regression and interaction analyses. Results: Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20–3.20), perceived stress (OR = 0.89, 95% CI: 0.81–0.98), knowledge (OR = 1.12, 95% CI: 1.02–1.23), and randomization group (OR = 1.48, 95% CI: 1.01–2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing. Conclusion: Evidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone. Genet Med 17 6, 467–475.
AbstractList As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling.PURPOSEAs genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling.Methods include multivariable logistic regression and interaction analyses.METHODSMethods include multivariable logistic regression and interaction analyses.Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20-3.20), perceived stress (OR = 0.89, 95% CI: 0.81-0.98), knowledge (OR = 1.12, 95% CI: 1.02-1.23), and randomization group (OR = 1.48, 95% CI: 1.01-2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing.RESULTSOf the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20-3.20), perceived stress (OR = 0.89, 95% CI: 0.81-0.98), knowledge (OR = 1.12, 95% CI: 1.02-1.23), and randomization group (OR = 1.48, 95% CI: 1.01-2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing.Evidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone.Genet Med 17 6, 467-475.CONCLUSIONEvidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone.Genet Med 17 6, 467-475.
As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling. Methods include multivariable logistic regression and interaction analyses. Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20-3.20), perceived stress (OR = 0.89, 95% CI: 0.81-0.98), knowledge (OR = 1.12, 95% CI: 1.02-1.23), and randomization group (OR = 1.48, 95% CI: 1.01-2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing. Evidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone.Genet Med 17 6, 467-475.
Purpose: As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling. Methods: Methods include multivariable logistic regression and interaction analyses. Results: Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20-3.20), perceived stress (OR = 0.89, 95% CI: 0.81-0.98), knowledge (OR = 1.12, 95% CI: 1.02-1.23), and randomization group (OR = 1.48, 95% CI: 1.01-2.16). Further, race/ ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing. Conclusion: Evidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone.
Purpose:As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling.Methods:Methods include multivariable logistic regression and interaction analyses.Results:Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20-3.20), perceived stress (OR = 0.89, 95% CI: 0.81-0.98), knowledge (OR = 1.12, 95% CI: 1.02-1.23), and randomization group (OR = 1.48, 95% CI: 1.01-2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing.Conclusion:Evidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone.Genet Med 17 6, 467-475.
Purpose: As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling. Methods: Methods include multivariable logistic regression and interaction analyses. Results: Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20–3.20), perceived stress (OR = 0.89, 95% CI: 0.81–0.98), knowledge (OR = 1.12, 95% CI: 1.02–1.23), and randomization group (OR = 1.48, 95% CI: 1.01–2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing. Conclusion: Evidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone. Genet Med 17 6, 467–475.
Author Peshkin, Beth N.
McKinnon, Wendy
Hooker, Gillian W.
Garber, Judy
Schwartz, Marc D.
Valdimarsdottir, Heiddis B.
Nusbaum, Rachel
Isaacs, Claudine
Kelly, Scott
Butrick, Morgan
Feeley, Lisa
Graves, Kristi
Wood, Marie
Jandorf, Lina
Luta, George
DeMarco, Tiffani
McCormick, Shelley R.
Author_xml – sequence: 1
  givenname: Morgan
  surname: Butrick
  fullname: Butrick, Morgan
  organization: Laboratory of Immunology, National Institute of Allergy and Infectious Disease, National Institutes of Health
– sequence: 2
  givenname: Scott
  orcidid: 0000-0002-0375-1040
  surname: Kelly
  fullname: Kelly, Scott
  organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University
– sequence: 3
  givenname: Beth N.
  surname: Peshkin
  fullname: Peshkin, Beth N.
  organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University
– sequence: 4
  givenname: George
  surname: Luta
  fullname: Luta, George
  organization: Department of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University
– sequence: 5
  givenname: Rachel
  surname: Nusbaum
  fullname: Nusbaum, Rachel
  organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University
– sequence: 6
  givenname: Gillian W.
  surname: Hooker
  fullname: Hooker, Gillian W.
  organization: Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health
– sequence: 7
  givenname: Kristi
  surname: Graves
  fullname: Graves, Kristi
  organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University
– sequence: 8
  givenname: Lisa
  surname: Feeley
  fullname: Feeley, Lisa
  organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University
– sequence: 9
  givenname: Claudine
  surname: Isaacs
  fullname: Isaacs, Claudine
  organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University
– sequence: 10
  givenname: Heiddis B.
  surname: Valdimarsdottir
  fullname: Valdimarsdottir, Heiddis B.
  organization: Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai
– sequence: 11
  givenname: Lina
  surname: Jandorf
  fullname: Jandorf, Lina
  organization: Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai
– sequence: 12
  givenname: Tiffani
  surname: DeMarco
  fullname: DeMarco, Tiffani
  organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University
– sequence: 13
  givenname: Marie
  surname: Wood
  fullname: Wood, Marie
  organization: Familial Cancer Program of the Vermont Cancer Center, University of Vermont College of Medicine
– sequence: 14
  givenname: Wendy
  surname: McKinnon
  fullname: McKinnon, Wendy
  organization: Familial Cancer Program of the Vermont Cancer Center, University of Vermont College of Medicine
– sequence: 15
  givenname: Judy
  surname: Garber
  fullname: Garber, Judy
  organization: Center for Cancer Genetics and Prevention, Dana Farber Cancer Institute, Harvard Medical School
– sequence: 16
  givenname: Shelley R.
  surname: McCormick
  fullname: McCormick, Shelley R.
  organization: Center for Cancer Genetics and Prevention, Dana Farber Cancer Institute, Harvard Medical School
– sequence: 17
  givenname: Marc D.
  surname: Schwartz
  fullname: Schwartz, Marc D.
  email: schwartm@georgetown.edu
  organization: Department of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25232856$$D View this record in MEDLINE/PubMed
BookMark eNqF0cuLFDEQB-AgK-5Db54l4MWDPZuk8zyu4xMWBNmzIZ2uGbN2J22SPuhfb4ZZRRbFU-rwVfFL1Tk6iSkCQk8p2VDS68t9mDeMUL6hTDxAZ1T0pCO9lCetJkZ3vSTkFJ2XcksIVT0jj9ApE6xnWsgz9Pl1KIvLoQYoOES8LtV9BZx2-NWn7RW9ZHgPEWrwuEKpIe4PyOHs4pjm8ANGXHNw06GhwgTLlxYO-7TGAlPTj9HDnZsKPLl7L9DN2zc32_fd9cd3H7ZX153nTNdOaS_MoAxzeuRGEyBKee1GOdBRGy0GbqQ0zrCdlryXSriBei_VQLViDPoL9OI4dsnp29qC2jkUD9PkIqS1WKracoSUhP-fSi2JFJrrRp_fo7dpzbH9w1LNuaKCC9PUszu1DjOMdslhdvm7_bXjBl4egc-plAy734QSezihbSe0hxPalrJxdo_7UF0NKdbswvSvpu7YVNrsuIf8R9S_-Z-0Dqr5
CitedBy_id crossref_primary_10_1089_gtmb_2020_29058_sjt
crossref_primary_10_1002_jgc4_1174
crossref_primary_10_1038_s41431_020_00783_9
crossref_primary_10_1007_s12687_017_0350_4
crossref_primary_10_1016_j_gim_2022_03_002
crossref_primary_10_1002_ajmg_c_31866
crossref_primary_10_1016_j_healthpol_2021_04_010
crossref_primary_10_1158_1055_9965_EPI_17_0389
crossref_primary_10_1016_j_gim_2022_02_004
crossref_primary_10_1002_jgc4_1773
crossref_primary_10_1007_s12687_021_00530_7
crossref_primary_10_1186_s12913_021_06489_y
crossref_primary_10_1007_s12687_019_00413_y
crossref_primary_10_1016_j_soc_2015_06_001
crossref_primary_10_3389_fpubh_2022_984926
crossref_primary_10_1016_j_cct_2023_107309
crossref_primary_10_3390_cancers10110435
crossref_primary_10_1093_jncimonographs_lgae004
crossref_primary_10_1002_cam4_3968
crossref_primary_10_1002_jgc4_1343
crossref_primary_10_1002_pd_6297
crossref_primary_10_1002_jgc4_1341
crossref_primary_10_1097_MLR_0000000000001405
crossref_primary_10_1002_jgc4_1424
crossref_primary_10_1007_s13187_019_01599_y
crossref_primary_10_1002_jgc4_1465
crossref_primary_10_1002_jgc4_1469
crossref_primary_10_1159_000503129
crossref_primary_10_1002_jgc4_1628
crossref_primary_10_3389_fdgth_2022_961128
crossref_primary_10_1002_cncr_35116
crossref_primary_10_1089_gtmb_2018_0253
crossref_primary_10_1016_j_ejca_2017_03_014
crossref_primary_10_1186_s13073_019_0691_1
crossref_primary_10_1200_EDBK_238937
crossref_primary_10_1002_cncr_34053
crossref_primary_10_1038_s41431_019_0390_9
crossref_primary_10_1177_1357633X211052220
crossref_primary_10_1007_s10897_017_0089_4
crossref_primary_10_1007_s12687_018_0379_z
crossref_primary_10_1007_s10897_016_9986_1
crossref_primary_10_1002_jgc4_1193
crossref_primary_10_1002_jgc4_1078
crossref_primary_10_1002_jgc4_1792
crossref_primary_10_1007_s10897_017_0082_y
crossref_primary_10_1002_jgc4_1230
crossref_primary_10_1002_jgc4_1351
crossref_primary_10_1093_tbm_ibac106
crossref_primary_10_1001_jamanetworkopen_2024_45363
crossref_primary_10_5301_tj_5000407
crossref_primary_10_1089_jwh_2019_7984
crossref_primary_10_2217_pme_15_39
crossref_primary_10_1016_j_clon_2018_04_004
crossref_primary_10_1038_s44276_023_00009_7
crossref_primary_10_1111_hiv_13701
crossref_primary_10_1080_03630242_2023_2237610
crossref_primary_10_1007_s12687_017_0347_z
crossref_primary_10_3390_curroncol28050301
crossref_primary_10_1007_s10549_018_4773_3
crossref_primary_10_1007_s10897_015_9848_2
crossref_primary_10_1007_s40615_018_00556_7
crossref_primary_10_1016_j_ejmg_2018_12_004
crossref_primary_10_1016_j_outlook_2019_06_004
crossref_primary_10_1136_ijgc_2019_001168
crossref_primary_10_1200_JCO_19_02010
crossref_primary_10_3389_fgene_2023_1239817
crossref_primary_10_1002_jgc4_1481
crossref_primary_10_1002_jgc4_1365
crossref_primary_10_1007_s10549_019_05515_2
crossref_primary_10_1007_s10689_016_9900_x
crossref_primary_10_1002_jgc4_1324
crossref_primary_10_1002_hast_1016
crossref_primary_10_1159_000489117
crossref_primary_10_1002_jgc4_1723
crossref_primary_10_1016_j_pec_2023_107648
crossref_primary_10_1080_09581596_2016_1179263
crossref_primary_10_1188_18_ONF_96_105
crossref_primary_10_3390_ijerph16203899
crossref_primary_10_1016_j_ctrv_2024_102695
crossref_primary_10_1093_jncics_pkx002
crossref_primary_10_1093_tbm_ibx051
crossref_primary_10_1007_s10897_015_9897_6
crossref_primary_10_1007_s10897_015_9899_4
ContentType Journal Article
Copyright The Author(s) 2015
Copyright Nature Publishing Group Jun 2015
Copyright_xml – notice: The Author(s) 2015
– notice: Copyright Nature Publishing Group Jun 2015
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
8FD
FR3
P64
RC3
DOI 10.1038/gim.2014.125
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
Genetics Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList MEDLINE - Academic
MEDLINE
Genetics Abstracts
ProQuest One Academic Middle East (New)

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1530-0366
EndPage 475
ExternalDocumentID 4265482571
25232856
10_1038_gim_2014_125
Genre Multicenter Study
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA108933
– fundername: NCI NIH HHS
  grantid: P30 CA051008
– fundername: Intramural NIH HHS
  grantid: Z99 AI999999
GroupedDBID ---
.-D
..I
.GJ
08G
39C
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
70F
7X7
88E
8FI
8FJ
AAFWJ
AAKAS
AALRI
AAXUO
AAYEP
AAYWO
ABAWZ
ABJNI
ABLJU
ABUWG
ACGFO
ACGFS
ACKTT
ACRQY
ACVFH
ADBBV
ADBIZ
ADCNI
ADVLN
ADZCM
AE3
AEJRE
AENEX
AEUPX
AEXYK
AFETI
AFJKZ
AFKRA
AFPUW
AFSHS
AFTRI
AGAYW
AGCQF
AHMBA
AHSBF
AHVBC
AIGII
AILAN
AITUG
AIZYK
AJRNO
AKBMS
AKRWK
AKYEP
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
AXYYD
BENPR
BKKNO
BPHCQ
BS7
BVXVI
C6C
CCPQU
CS3
DNIVK
DU5
EBS
EE.
EFKBS
EIOEI
EJD
EX3
F5P
FDB
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
H0~
HMCUK
JF9
JG8
JK3
JSO
K-O
KD2
M1P
M41
N9A
NQJWS
N~M
OAG
OAH
ODA
OK1
OLG
OVD
OWU
OWV
OWW
OWX
OWY
OWZ
P-K
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
R58
RNT
RNTTT
ROL
S4R
SNYQT
SOHCF
SOJ
SRMVM
SWTZT
T8P
TAOOD
TBHMF
TDRGL
TEORI
TSG
UKHRP
VVN
W3M
WOQ
WOW
XXN
XYM
YFH
ZFV
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
8FD
FR3
P64
RC3
ID FETCH-LOGICAL-c428t-78c59b792a8d4980e077c8ad6b1d8985b49669a92f8643675ab1cc67b18722e3
IEDL.DBID 7X7
ISSN 1098-3600
1530-0366
IngestDate Fri Jul 11 10:18:46 EDT 2025
Fri Jul 11 15:04:17 EDT 2025
Fri Jul 25 07:27:47 EDT 2025
Mon Jul 21 06:02:55 EDT 2025
Tue Jul 01 02:59:06 EDT 2025
Thu Apr 24 22:59:11 EDT 2025
Mon Jul 21 06:06:54 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords genetic counseling
psychosocial predictors
cancer
genetic testing
telephone counseling
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c428t-78c59b792a8d4980e077c8ad6b1d8985b49669a92f8643675ab1cc67b18722e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-0375-1040
0000000203751040
OpenAccessLink https://www.nature.com/articles/gim.2014.125
PMID 25232856
PQID 1844715459
PQPubID 2043492
PageCount 9
ParticipantIDs proquest_miscellaneous_1712556604
proquest_miscellaneous_1686065848
proquest_journals_1844715459
pubmed_primary_25232856
crossref_primary_10_1038_gim_2014_125
crossref_citationtrail_10_1038_gim_2014_125
springer_journals_10_1038_gim_2014_125
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-06-01
PublicationDateYYYYMMDD 2015-06-01
PublicationDate_xml – month: 06
  year: 2015
  text: 2015-06-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
– name: Bethesda
PublicationSubtitle Official journal of the American College of Medical Genetics and Genomics
PublicationTitle Genetics in medicine
PublicationTitleAbbrev Genet Med
PublicationTitleAlternate Genet Med
PublicationYear 2015
Publisher Nature Publishing Group US
Elsevier Limited
Publisher_xml – name: Nature Publishing Group US
– name: Elsevier Limited
References VigHSWangCThe evolution of personalized cancer genetic counseling in the era of personalized medicineFam Cancer20121153954410.1007/s10689-012-9524-8
LevyDEByfieldSDComstockCBUnderutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at riskGenet Med20111334935510.1097/GIM.0b013e3182091ba4
HoskinsLMWerner-LinAA multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25J Genet Couns201322273810.1007/s10897-012-9521-y
BusijaLPausenbergerEHainesTPHaymesSBuchbinderROsborneRHAdult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL)Arthritis Care Res (Hoboken)201163suppl 11S383S41210.1002/acr.20541
HoskinsLMGreeneMHAnticipatory loss and early mastectomy for young female BRCA1/2 mutation carriersQual Health Res2012221633164610.1177/1049732312458182
StreetRLJrO’MalleyKJCooperLAHaidetPUnderstanding concordance in patient-physician relationships: personal and ethnic dimensions of shared identityAnn Fam Med2008619820510.1370/afm.821
US Preventive Services Task Force. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Draft Recommendation Statement. April 2013. AHRQ Publication No. 12-05164-EF-2. http://www.uspreventiveservicestaskforce.org/uspstf12/brcatest/draftrecbrcatest.htm.
BaumanisLEvansJPCallananNSussweinLRTelephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfactionJ Genet Couns2009184474631:STN:280:DC%2BD1MnmtlyntQ%3D%3D10.1007/s10897-009-9238-8
ErblichJBrownKKimYValdimarsdottirHBLivingstonBEBovbjergDHDevelopment and validation of a Breast Cancer Genetic Counseling Knowledge QuestionnairePatient Educ Couns20055618219110.1016/j.pec.2004.02.007
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian. V.1.2014. http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf.
McKinstryBHammersleyVBurtonCThe quality, safety and content of telephone and face-to-face consultations: a comparative studyQual Saf Health Care2010192983031:STN:280:DC%2BC3cjjtVWmtA%3D%3D10.1136/qshc.2008.027763
BrierleyKLBlouchECogswellWAdverse events in cancer genetic testing: medical, ethical, legal, and financial implicationsCancer J20121830330910.1097/PPO.0b013e3182609490
McKinstryBSheikhAUnresolved questions in telephone consultingJ R Soc Med2006992310.1258/jrsm.99.1.2
O’ConnorAMValidation of a decisional conflict scaleMed Decis Making199515253010.1177/0272989X9501500105
FormanADHallMJInfluence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancerBreast J200915suppl 1S56S6210.1111/j.1524-4741.2009.00798.x
CohenSKamarckTMermelsteinRA global measure of perceived stressJ Health Soc Behav1983243853961:STN:280:DyaL2c7js12iug%3D%3D10.2307/2136404
GravesKDChristopherJHarrisonTMPeshkinBNIsaacsCSheppardVBProviders’ perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American womenJ Genet Couns20112067468910.1007/s10897-011-9396-3
BealACChouSCPalmerRHTestaMANewmanCEzhuthachanSThe changing face of race: risk factors for neonatal hyperbilirubinemiaPediatrics20061171618162510.1542/peds.2005-1203
BradburyARPatrick-MillerLFetzerDGenetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test resultsClin Genet2011791251311:STN:280:DC%2BC3M%2FpsVamtw%3D%3D10.1111/j.1399-0004.2010.01540.x
MackenzieAPatrick-MillerLBradburyARControversies in communication of genetic risk for hereditary breast cancerBreast J200915suppl 1S25S3210.1111/j.1524-4741.2009.00800.x
CukierYRThompsonHSSussnerKFactors associated with psychological distress among women of African descent at high risk for BRCA mutationsJ Genet Couns20132210110710.1007/s10897-012-9510-1
WhamDVuTChan-SmutkoGKobelkaCUrbauerDHealdBAssessment of clinical practices among cancer genetic counselorsFam Cancer2010945946810.1007/s10689-010-9326-9
GordonHSStreetRLJrSharfBFSouchekJRacial differences in doctors’ information-giving and patients’ participationCancer20061071313132010.1002/cncr.22122
DougallALSmithAWSomersTJPoslusznyDMRubinsteinWSBaumACoping with genetic testing for breast cancer susceptibilityPsychosom Med200971981051:CAS:528:DC%2BD1MXitlajtg%3D%3D10.1097/PSY.0b013e318190d7b4
HelmesAWCulverJOBowenDJResults of a randomized study of telephone versus in-person breast cancer risk counselingPatient Educ Couns2006649610310.1016/j.pec.2005.12.002
Kinney AY, Butler KM, Boucher KM, et al. Telephone vs. in-person genetic counseling for hereditary breast and ovarian cancer in urban and rural women: a cluster randomized trial. J Natl Cancer Inst, in press.
HorowitzMWilnerNAlvarezWImpact of Event Scale: a measure of subjective stressPsychosom Med1979412092181:STN:280:DyaE1M3kslGjug%3D%3D10.1097/00006842-197905000-00004
ThorntonRLPoweNRRoterDCooperLAPatient-physician social concordance, medical visit communication and patients’ perceptions of health care qualityPatient Educ Couns201185e201e20810.1016/j.pec.2011.07.015
National Society of Genetic Counselors. 2012 Professional Status Survey: Executive Summary. http://nsgc.org/p/cm/ld/fid=68.
AghaZRoterDLSchapiraRMAn evaluation of patient-physician communication style during telemedicine consultationsJ Med Internet Res200911e3610.2196/jmir.1193
BerryDAIversenESJrGudbjartssonDFBRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genesJ Clin Oncol200220270127121:CAS:528:DC%2BD38XkvF2mtrs%3D10.1200/JCO.2002.05.121
CohenSAMarvinMLRileyBDVigHSRousseauJAGustafsonSLIdentification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task ForceJ Genet Couns20132241142110.1007/s10897-013-9588-0
SmedleyBDStithAYNelsonARUnequal Treatment: Confronting Racial and Ethnic Disparities in Health Care.2003National Academies Press
SchwartzMDValdimarsdottirHBPeshkinBNRandomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancerJ Clin Oncol20143261862610.1200/JCO.2013.51.3226
PeshkinBNDemarcoTAGravesKDTelephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trialGenet Test200812375210.1089/gte.2006.0525
ArmstrongKMiccoECarneyAStopferJPuttMRacial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancerJAMA2005293172917361:CAS:528:DC%2BD2MXjtlWmtLc%3D10.1001/jama.293.14.1729
LipkusIMKleinWMRimerBKCommunicating breast cancer risks to women using different formatsCancer Epidemiol Biomarkers Prev2001108958981:STN:280:DC%2BD3MvktlahtQ%3D%3D11489757
CooperLARoterDLJohnsonRLFordDESteinwachsDMPoweNRPatient-centered communication, ratings of care, and concordance of patient and physician raceAnn Intern Med200313990791510.7326/0003-4819-139-11-200312020-00009
JohnsonRLRoterDPoweNRCooperLAPatient race/ethnicity and quality of patient-physician communication during medical visitsAm J Public Health2004942084209010.2105/AJPH.94.12.2084
WareJJrKosinskiMKellerSDA 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validityMed Care19963422023310.1097/00005650-199603000-00003
Street (10.1038/gim.2014.125_bb0190)
Cukier (10.1038/gim.2014.125_bb0165)
Levy (10.1038/gim.2014.125_bb0155)
Agha (10.1038/gim.2014.125_bb0200)
Busija (10.1038/gim.2014.125_bb0130)
Helmes (10.1038/gim.2014.125_bb0065)
Lipkus (10.1038/gim.2014.125_bb0105)
Peshkin (10.1038/gim.2014.125_bb0090)
Thornton (10.1038/gim.2014.125_bb0195)
Dougall (10.1038/gim.2014.125_bb0135)
Cooper (10.1038/gim.2014.125_bb0170)
10.1038/gim.2014.125_bb0010
Baumanis (10.1038/gim.2014.125_bb0035)
10.1038/gim.2014.125_bb0015
Berry (10.1038/gim.2014.125_bb0095)
Hoskins (10.1038/gim.2014.125_bb0145)
Horowitz (10.1038/gim.2014.125_bb0115)
Bradbury (10.1038/gim.2014.125_bb0040)
10.1038/gim.2014.125_bb0075
Vig (10.1038/gim.2014.125_bb0030)
Graves (10.1038/gim.2014.125_bb0150)
Cohen (10.1038/gim.2014.125_bb0120)
Johnson (10.1038/gim.2014.125_bb0180)
Armstrong (10.1038/gim.2014.125_bb0080)
Wham (10.1038/gim.2014.125_bb0045)
McKinstry (10.1038/gim.2014.125_bb0060)
Cohen (10.1038/gim.2014.125_bb0205)
Erblich (10.1038/gim.2014.125_bb0100)
McKinstry (10.1038/gim.2014.125_bb0055)
Forman (10.1038/gim.2014.125_bb0085)
Ware (10.1038/gim.2014.125_bb0125)
Gordon (10.1038/gim.2014.125_bb0175)
Brierley (10.1038/gim.2014.125_bb0025)
Hoskins (10.1038/gim.2014.125_bb0140)
Beal (10.1038/gim.2014.125_bb0160)
Smedley (10.1038/gim.2014.125_bb0185) 2003
10.1038/gim.2014.125_bb0020
Mackenzie (10.1038/gim.2014.125_bb0070)
O’Connor (10.1038/gim.2014.125_bb0110)
Schwartz (10.1038/gim.2014.125_bb0050)
References_xml – reference: BerryDAIversenESJrGudbjartssonDFBRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genesJ Clin Oncol200220270127121:CAS:528:DC%2BD38XkvF2mtrs%3D10.1200/JCO.2002.05.121
– reference: ErblichJBrownKKimYValdimarsdottirHBLivingstonBEBovbjergDHDevelopment and validation of a Breast Cancer Genetic Counseling Knowledge QuestionnairePatient Educ Couns20055618219110.1016/j.pec.2004.02.007
– reference: ThorntonRLPoweNRRoterDCooperLAPatient-physician social concordance, medical visit communication and patients’ perceptions of health care qualityPatient Educ Couns201185e201e20810.1016/j.pec.2011.07.015
– reference: CooperLARoterDLJohnsonRLFordDESteinwachsDMPoweNRPatient-centered communication, ratings of care, and concordance of patient and physician raceAnn Intern Med200313990791510.7326/0003-4819-139-11-200312020-00009
– reference: SchwartzMDValdimarsdottirHBPeshkinBNRandomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancerJ Clin Oncol20143261862610.1200/JCO.2013.51.3226
– reference: WareJJrKosinskiMKellerSDA 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validityMed Care19963422023310.1097/00005650-199603000-00003
– reference: HoskinsLMGreeneMHAnticipatory loss and early mastectomy for young female BRCA1/2 mutation carriersQual Health Res2012221633164610.1177/1049732312458182
– reference: StreetRLJrO’MalleyKJCooperLAHaidetPUnderstanding concordance in patient-physician relationships: personal and ethnic dimensions of shared identityAnn Fam Med2008619820510.1370/afm.821
– reference: BrierleyKLBlouchECogswellWAdverse events in cancer genetic testing: medical, ethical, legal, and financial implicationsCancer J20121830330910.1097/PPO.0b013e3182609490
– reference: PeshkinBNDemarcoTAGravesKDTelephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trialGenet Test200812375210.1089/gte.2006.0525
– reference: GravesKDChristopherJHarrisonTMPeshkinBNIsaacsCSheppardVBProviders’ perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American womenJ Genet Couns20112067468910.1007/s10897-011-9396-3
– reference: SmedleyBDStithAYNelsonARUnequal Treatment: Confronting Racial and Ethnic Disparities in Health Care.2003National Academies Press
– reference: LipkusIMKleinWMRimerBKCommunicating breast cancer risks to women using different formatsCancer Epidemiol Biomarkers Prev2001108958981:STN:280:DC%2BD3MvktlahtQ%3D%3D11489757
– reference: JohnsonRLRoterDPoweNRCooperLAPatient race/ethnicity and quality of patient-physician communication during medical visitsAm J Public Health2004942084209010.2105/AJPH.94.12.2084
– reference: McKinstryBHammersleyVBurtonCThe quality, safety and content of telephone and face-to-face consultations: a comparative studyQual Saf Health Care2010192983031:STN:280:DC%2BC3cjjtVWmtA%3D%3D10.1136/qshc.2008.027763
– reference: MackenzieAPatrick-MillerLBradburyARControversies in communication of genetic risk for hereditary breast cancerBreast J200915suppl 1S25S3210.1111/j.1524-4741.2009.00800.x
– reference: National Society of Genetic Counselors. 2012 Professional Status Survey: Executive Summary. http://nsgc.org/p/cm/ld/fid=68.
– reference: Kinney AY, Butler KM, Boucher KM, et al. Telephone vs. in-person genetic counseling for hereditary breast and ovarian cancer in urban and rural women: a cluster randomized trial. J Natl Cancer Inst, in press.
– reference: ArmstrongKMiccoECarneyAStopferJPuttMRacial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancerJAMA2005293172917361:CAS:528:DC%2BD2MXjtlWmtLc%3D10.1001/jama.293.14.1729
– reference: LevyDEByfieldSDComstockCBUnderutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at riskGenet Med20111334935510.1097/GIM.0b013e3182091ba4
– reference: DougallALSmithAWSomersTJPoslusznyDMRubinsteinWSBaumACoping with genetic testing for breast cancer susceptibilityPsychosom Med200971981051:CAS:528:DC%2BD1MXitlajtg%3D%3D10.1097/PSY.0b013e318190d7b4
– reference: FormanADHallMJInfluence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancerBreast J200915suppl 1S56S6210.1111/j.1524-4741.2009.00798.x
– reference: WhamDVuTChan-SmutkoGKobelkaCUrbauerDHealdBAssessment of clinical practices among cancer genetic counselorsFam Cancer2010945946810.1007/s10689-010-9326-9
– reference: McKinstryBSheikhAUnresolved questions in telephone consultingJ R Soc Med2006992310.1258/jrsm.99.1.2
– reference: BradburyARPatrick-MillerLFetzerDGenetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test resultsClin Genet2011791251311:STN:280:DC%2BC3M%2FpsVamtw%3D%3D10.1111/j.1399-0004.2010.01540.x
– reference: HelmesAWCulverJOBowenDJResults of a randomized study of telephone versus in-person breast cancer risk counselingPatient Educ Couns2006649610310.1016/j.pec.2005.12.002
– reference: National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian. V.1.2014. http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf.
– reference: US Preventive Services Task Force. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Draft Recommendation Statement. April 2013. AHRQ Publication No. 12-05164-EF-2. http://www.uspreventiveservicestaskforce.org/uspstf12/brcatest/draftrecbrcatest.htm.
– reference: VigHSWangCThe evolution of personalized cancer genetic counseling in the era of personalized medicineFam Cancer20121153954410.1007/s10689-012-9524-8
– reference: O’ConnorAMValidation of a decisional conflict scaleMed Decis Making199515253010.1177/0272989X9501500105
– reference: BealACChouSCPalmerRHTestaMANewmanCEzhuthachanSThe changing face of race: risk factors for neonatal hyperbilirubinemiaPediatrics20061171618162510.1542/peds.2005-1203
– reference: HorowitzMWilnerNAlvarezWImpact of Event Scale: a measure of subjective stressPsychosom Med1979412092181:STN:280:DyaE1M3kslGjug%3D%3D10.1097/00006842-197905000-00004
– reference: BusijaLPausenbergerEHainesTPHaymesSBuchbinderROsborneRHAdult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL)Arthritis Care Res (Hoboken)201163suppl 11S383S41210.1002/acr.20541
– reference: HoskinsLMWerner-LinAA multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25J Genet Couns201322273810.1007/s10897-012-9521-y
– reference: CohenSAMarvinMLRileyBDVigHSRousseauJAGustafsonSLIdentification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task ForceJ Genet Couns20132241142110.1007/s10897-013-9588-0
– reference: AghaZRoterDLSchapiraRMAn evaluation of patient-physician communication style during telemedicine consultationsJ Med Internet Res200911e3610.2196/jmir.1193
– reference: BaumanisLEvansJPCallananNSussweinLRTelephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfactionJ Genet Couns2009184474631:STN:280:DC%2BD1MnmtlyntQ%3D%3D10.1007/s10897-009-9238-8
– reference: GordonHSStreetRLJrSharfBFSouchekJRacial differences in doctors’ information-giving and patients’ participationCancer20061071313132010.1002/cncr.22122
– reference: CohenSKamarckTMermelsteinRA global measure of perceived stressJ Health Soc Behav1983243853961:STN:280:DyaL2c7js12iug%3D%3D10.2307/2136404
– reference: CukierYRThompsonHSSussnerKFactors associated with psychological distress among women of African descent at high risk for BRCA mutationsJ Genet Couns20132210110710.1007/s10897-012-9510-1
– ident: 10.1038/gim.2014.125_bb0145
– ident: 10.1038/gim.2014.125_bb0010
– ident: 10.1038/gim.2014.125_bb0130
– ident: 10.1038/gim.2014.125_bb0085
– ident: 10.1038/gim.2014.125_bb0040
– ident: 10.1038/gim.2014.125_bb0150
– ident: 10.1038/gim.2014.125_bb0115
– ident: 10.1038/gim.2014.125_bb0060
– ident: 10.1038/gim.2014.125_bb0075
– ident: 10.1038/gim.2014.125_bb0125
– ident: 10.1038/gim.2014.125_bb0205
– ident: 10.1038/gim.2014.125_bb0025
– ident: 10.1038/gim.2014.125_bb0045
– ident: 10.1038/gim.2014.125_bb0120
– ident: 10.1038/gim.2014.125_bb0155
– ident: 10.1038/gim.2014.125_bb0055
– ident: 10.1038/gim.2014.125_bb0035
– ident: 10.1038/gim.2014.125_bb0175
– ident: 10.1038/gim.2014.125_bb0195
– ident: 10.1038/gim.2014.125_bb0140
– ident: 10.1038/gim.2014.125_bb0015
– ident: 10.1038/gim.2014.125_bb0110
– ident: 10.1038/gim.2014.125_bb0050
– ident: 10.1038/gim.2014.125_bb0095
– ident: 10.1038/gim.2014.125_bb0135
– ident: 10.1038/gim.2014.125_bb0170
– ident: 10.1038/gim.2014.125_bb0070
– ident: 10.1038/gim.2014.125_bb0030
– ident: 10.1038/gim.2014.125_bb0065
– ident: 10.1038/gim.2014.125_bb0105
– ident: 10.1038/gim.2014.125_bb0080
– year: 2003
  ident: 10.1038/gim.2014.125_bb0185
– ident: 10.1038/gim.2014.125_bb0160
– ident: 10.1038/gim.2014.125_bb0200
– ident: 10.1038/gim.2014.125_bb0020
– ident: 10.1038/gim.2014.125_bb0100
– ident: 10.1038/gim.2014.125_bb0165
– ident: 10.1038/gim.2014.125_bb0180
– ident: 10.1038/gim.2014.125_bb0090
– ident: 10.1038/gim.2014.125_bb0190
SSID ssj0017320
Score 2.4198635
Snippet Purpose: As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study...
As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines...
Purpose:As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study...
Purpose: As genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 467
SubjectTerms 692/699/67/1347
692/699/67/1517/1709
692/700/139/1512
692/700/228/2050/1510
Adult
Biomedicine
Female
Genes, BRCA1
Genes, BRCA2
Genetic Counseling
Genetic Testing
Healthcare Disparities
Hereditary Breast and Ovarian Cancer Syndrome - diagnosis
Hereditary Breast and Ovarian Cancer Syndrome - epidemiology
Hereditary Breast and Ovarian Cancer Syndrome - genetics
Human Genetics
Humans
Laboratory Medicine
Middle Aged
Odds Ratio
original-research-article
Risk Factors
Telephone
SummonAdditionalLinks – databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bS91AEB7UUvFFrPUSL2WFti8aTTbZ26OeVqSgD8WCTw17ixzUHNGcB_31zuaGopa-BTJLhtndfDPMzDcAXy1lmntbxtzmSZxLZ_HOaRFrrm2aOCY0Db3Dp2f85E_-64JdzMBe3wvTFO03lJbNb7qvDju4HIe28TTfR0CehQ-BtD2c5xEfDTkDkdGWe0DJOEMc78rck0y-WP0SgF55la8yog3QHC_BYuchksNWp08w46tl-NjOjHxYhvnTLhv-Gf7-GN-HIYKBE5WMKzK9rfWVJ5OSHP0eHaYHlODpCE2KpA5cGtVlENIE0clNbsaP3pFmZkdYUCP6hCp1T-zQpL4C58c_z0cncTcvIbYYRNSxkJYpIxTV0uVKJj4RwkrtuEmdVJKZHGMbpRUtJfohGClok1rLhUmloNRnqzBX4YfWgWTGp6VWiS5Vlpe-VMaZwNviGKOGMhvBbm_DwnZc4mGkxXXR5LQzWaDFi2DxAi0ewbdB-rbl0HhHbqvfjqK7SfcFRqCIn-jnqQh2htd4B0JiQ1d-MkUZLnnjSsl_yIg0sK3xJI9grd3qQRmK0TiVjEfwvd_7Zwq8oenG_wpuwgI-sra2bAvm6rup30YvpjZfmsP7BOv47Mw
  priority: 102
  providerName: Springer Nature
Title Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling
URI https://link.springer.com/article/10.1038/gim.2014.125
https://www.ncbi.nlm.nih.gov/pubmed/25232856
https://www.proquest.com/docview/1844715459
https://www.proquest.com/docview/1686065848
https://www.proquest.com/docview/1712556604
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB-0RfFFtH5Fa1lBfZHY7Cb79STt2VKEFikV7smwX5FDvTu93IP-9c4kuVio9jFkQoaZ3Z2ZnZnfALwMQjqVQpOrUBV5ZWLAPed07pQLvIhSO0G9w6dn6uRT9WEqp8OF22ooq9ycid1BHReB7sj3MRLBcxTtvX23_JHT1CjKrg4jNG7CNkGXUUmXno4BF9el6NEIrMlLtOxD4XtRYtA3ozZ0Xr3lNCT7skm64mdeyZF2puf4HtwdfEZ20Cv5PtxI8x241U-R_LUDt0-H_PgD-Px-tqKxgoSSymZztl627mtii4Ydnk8O-L5guF6obZG1hK4x_0JEjqG9iovvs98psm6KB33Qoj2iuvXEwti2_hAujo8uJif5MEEhDxhWtLk2QVqvrXAmVtYUqdA6GBeV59FYI32F0Y51VjQGPROMHZznISjtudFCpPIRbM3xR0-AlT7xxtnCNbasmtRYHz0huUQphRcyZPBmI8M6DOjiNOTiW91luUtTo8RrkniNEs_g1Ui97FE1_kO3u1FHPeytVf13JWTwYnyNu4JSHW6eFmukUUZ1zpW5hkZzwl9TRZXB417VIzMC43NhpMrg9Ub3lxj4B6dPr-f0GdxBStnXmO3CVvtznZ6jN9P6vW7J7sH24dHZx3N8mqjJHyo_83M
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtNA9Km0YrkgKJuhwCBRLsjUHnu2A0JdldImQlWQesKazSgCnEAcofJP_CNvvIRKhd569hv76e3jtwG8tJRp7m0Zc5sncS6dRZ3TItZc2zRxTGgaeoeHIz74mL8_Zacr8LvvhQlllb1NbAy1m9rwj3wLbyJoR9Hfq3ez73HYGhWyq_0KjVYsjvzZT7yyzd8e7iF_Nyk92B_vDuJuq0BsMdSuYyEtU0YoqqXLlUx8IoSV2nGTOqkkMzneAJRWtJTorTGe1ia1lguTSkGpz_C112ANnyRoB9Z29kcfTpZpC5HRdvyBkjECJF2lfZLhLXMS-t7T_E0atnKf94EXAtsLSdnG1x3cgdtdkEq2W6m6Cyu-Wofr7drKs3W4MewS8vfg095kHvYYhrGsZFKRxazWXzyZlmTnZHc73aIEBTT0SZI6jPOoPgcgTdBBuum3yS_vSLM2JByo0QGGQnlP7LJP_j6Mr4K4D2C1wg89ApIZn5ZaJbpUWV76UhlnwugYxxg1lNkIXvc0LGw3zjxs1fhaNGn1TBZI8SJQvECKR7C5hJ61Yzz-A7fRs6PolHle_BW9CF4sH6MahtyKrvx0gTBc8iaak5fAiDQMfONJHsHDltVLZCjD0FYyHsGrnvfnEPgHpo8vx_Q53ByMh8fF8eHo6AncwlOsLXDbgNX6x8I_xVCqNs86ASZQXLHK_AH7pS0u
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKqLggKK9AASNRLihs7MSvA0Kly6qltEKoSHtq5NgOWgHZhc0KlT_j7xjnRaVCbz1nnIzm4ZnJvACeWcaN8LaMhc2SOFPOos4ZGRthLE0cl4aF3uHDI7H3KXs35dM1-N33woSyyv5ObC5qN7fhH_kIIxG8R9He61HZlUV8GE9eL77HYYNUyLT26zRaETnwpz8xfFu-2h8jr7cZm7w93t2Luw0DsUW3u46lslwXUjOjXKZV4hMprTJOFNQprXiRYTSgjWalQsuNvrUpqLVCFlRJxnyKr70CV2XKaVAxOR1iPSpT1g5C0CpO0anoau6TFOPNWeiAp9lLGvZzn7WG51zcc-nZxupNbsKNzl0lO6183YI1X23CtXaB5ekmbBx2qfnbcDKeLcNGwzCglcwqslrU5osn85K8-bi7Q0eMoKiGjklSh8Ee1ecAZAiaSjf_NvvlHWkWiIQDNZrCUDLviR065u_A8WWQ9i6sV_ih-0DSwtPS6MSUOs1KX-rCFWGIjOOcFYzbCF70NMxtN9g87Nf4mjcJ9lTlSPE8UDxHikewPUAv2oEe_4Hb6tmRd2q9zP8KYQRPh8eokCHLYio_XyGMUKLx69QFMJKG0W8iySK417J6QIZxdHIVFxE873l_BoF_YPrgYkyfwAYqSv5-_-jgIVzHQ7ytdNuC9frHyj9Cn6ouHjfSSyC_ZG35A-ZHL_4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Disparities+in+uptake+of+BRCA1%2F2+genetic+testing+in+a+randomized+trial+of+telephone+counseling&rft.jtitle=Genetics+in+medicine&rft.au=Butrick%2C+Morgan&rft.au=Kelly%2C+Scott&rft.au=Peshkin%2C+Beth+N&rft.au=Luta%2C+George&rft.date=2015-06-01&rft.pub=Elsevier+Limited&rft.issn=1098-3600&rft.eissn=1530-0366&rft.volume=17&rft.issue=6&rft.spage=467&rft_id=info:doi/10.1038%2Fgim.2014.125&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=4265482571
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-3600&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-3600&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-3600&client=summon